Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Altrenogest (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Megestrol |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Dydrogesterone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethisterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norethisterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Etynodiol diacetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norgestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Noretynodrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Desogestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Hydroxyprogesterone (substance) |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Medroxyprogesterone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Flurogestone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norgestimate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Delmadinone acetate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Drospirenone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norelgestromin (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Gestrinone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Allylestrenol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Lynestrenol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Etonogestrel (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Gestodene (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Gestonorone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Etynodiol |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norgestomet (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 50 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Progesterone 40 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Progesterone 80 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 200 mg vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 400 mg vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 50 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Estradiol valerate 2 mg and norethisterone 700 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
ethinylestradiol 35 µg + norethisteron 1 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
ethinylestradiol + gestoden + placebo /75 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
ethinylestradiol 20 µg + progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
ethinylestradiol 30 µg + progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ethinylestradiol 35mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
ethinylestradiol 50 µg + progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing progesterone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron til rektal/vaginal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progestinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
1 |
Product containing progesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
kombinationspræparat med østrogen og progestin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing melengestrol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
melengestrolacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 20 mg creme til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Combined oestogen+progestogen preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Menstrual disorder comb.preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Progesterone - only contraceptives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Progesterone 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
progesteron 50 mg/ml olie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Progesterone 100mg softgels (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
levonorgestrel 125 µg/ethinylestradiol 30 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
levonorgestrel 50 µg/ethinylestradiol 30 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
levonorgestrel 75 µg/ethinylestradiol 40 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Nomegestrol (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Dienogest (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ulipristal (substance) |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Promegestone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norethisterone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Norethisterone enantate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Pregnanediolone |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Megestrol acetate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Hydroxyprogesterone caproate |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Delmadinone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Ulipristal acetate (substance) |
Is a |
False |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Levonorgestrel |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Gestonorone caproate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Segesterone acetate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Segesterone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Nomegestrol acetate (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Medrogestone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
46,XX disorder of sex development caused by synthetic oral progestogen (disorder) |
Causative agent |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
1 |
Oxendolone |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Tibolone (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|
Allylestrenol micronized (substance) |
Is a |
True |
Synthetic progestogen (substance) |
Inferred relationship |
Some |
|